Everything below concerns 长效肽设计. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-04-03. Numbers and descriptions here follow the published literature rather than marketing material.
Semaglutide is a synthetic peptide that acts as an agonist at the glucagon-like peptide-1 receptor. It is a structural analogue of human GLP-1(7-37), modified to resist enzymatic degradation by dipeptidyl peptidase-4. The peptide backbone contains alpha-aminoisobutyric acid at position 8, a substitution that stabilises the helix and slows cleavage. A fatty diacid side chain attached through a linker at lysine 34 promotes binding to serum albumin, which extends the circulating half-life. These two modifications together allow less frequent administration than native GLP-1 requires.
Activation of the GLP-1 receptor couples to Gs signalling and raises intracellular cyclic AMP in pancreatic beta cells. The resulting insulin release depends on prevailing glucose concentrations, so the effect is greater when glucose is elevated. Receptor engagement also suppresses glucagon secretion and slows gastric emptying, which flattens post-meal glucose excursions. In the central nervous system, signalling in hypothalamic and brainstem regions is associated with reduced appetite and lower energy intake. Studies continue to examine effects on cardiac, renal and hepatic endpoints; whether those benefits are independent of weight change remains an open question.
Clinical development of this compound followed earlier short-acting GLP-1 analogues that required frequent injection. Once-weekly subcutaneous formulations entered use after 2017, and an oral formulation using a permeation enhancer later became available. The oral version pairs the peptide with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, a carrier that improves uptake across the gastric epithelium. Interest has expanded from glycaemic control into weight management and metabolic liver disease. Regulatory status and approved indications differ between countries, and the product remains subject to ongoing safety monitoring.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released after nutrient intake. The molecule contains 31 amino acid residues and differs from the native sequence at several positions. A non-natural residue at position eight resists the enzyme that normally truncates the hormone, while a lysine-linked fatty diacid side chain promotes binding to serum albumin. These two modifications extend the circulating half-life from minutes to roughly one week. The peptide is produced by solid-phase synthesis followed by selective acylation, and its identity and purity are confirmed by spectrometric and chromatographic techniques.
The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | Parent peptide; salt forms also reported |
| Molecular mass | about 4113.6 Da | Average mass of the free peptide |
| Peptide length | 31 amino acids | Backbone related to GLP-1(7-37) |
| Key substitution | Aib at position 8 | Blocks DPP-4 cleavage |
| Albumin binding | Via C-18 diacid side chain | Prolongs circulation time |
Semaglutide 是一种经结构修饰的胰高血糖素样肽-1 类似物，其主链与内源性 GLP-1(7-36) 约有百分之九十四的序列一致性。第 8 位丙氨酸被 α-氨基异丁酸取代，使二肽基肽酶-4 无法识别原有切割位点。第 34 位赖氨酸换为精氨酸，进一步降低酶解速率。第 26 位赖氨酸经间隔基连接一条含十八个碳的二酸脂肪链，该侧链赋予分子与血浆白蛋白结合的能力。
该分子作为 GLP-1 受体的选择性激动剂发挥作用，受体属于 B 类 G 蛋白偶联受体家族，激活后经 Gs 通路提升细胞内环腺苷酸水平。在胰腺 β 细胞，信号促进葡萄糖依赖性的胰岛素释放，血糖偏低时该作用明显减弱。在胰岛 α 细胞，胰高血糖素分泌受到抑制。中枢神经系统与胃肠道同样存在受体表达，相应信号参与食欲调节以及胃排空速率的降低。
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
Woods and his family are targeted in a campaign of harassment by the security police, including bullets fired into the family home, vandalism, and the delivery of t-shirts with Biko's image that have been dusted with itching powder. He later decides to seek asylum in Britain in order to expose the corrupt and racist nature of the South African authorities. After a long trek, Woods is eventually able to escape to the Kingdom of Lesotho, disguised as a priest. His wife Wendy and their family later join him. With the aid of Australian journalist Bruce Haigh, the British High Commission in Maseru, and the Government of Lesotho, they are flown under United Nations passports and with one Lesotho official over South African territory, via Botswana, to London, where they were granted political asylum. The film's epilogue displays a long list of anti-apartheid activists (including Biko), who died under suspicious circumstances while imprisoned by the Government whilst the song Nkosi Sikelel' iAfrika is sung.
== Solubility == Another property of nanoparticles that is heavily influenced by the surfactants is the solubility of the nanoparticle. One can imagine that a metallic nanoparticle would not dissolve well in organic solvents. By adding the surfactants the nanoparticles will stay more evenly dispersed throughout the solvent. This is due to the, often, amphiphilic nature of the surfactants. The interfacial layer can be used to essentially tune the solubility of nanoparticles in different media, which can range from extremely hydrophilic to hydrophobic.
The metals nickel, chromium, and copper coated with silver have been used to make the normally thin-wired e-cigarette heating elements. The atomizers and heating coils possibly contain aluminum. They likely account for most of the aluminum in the e-cigarette vapor. The chromium used to make the atomizers and heating coils is probably the origin of the chromium. Copper is commonly used to make atomizers. Atomizers and heating coils commonly contain iron. Cadmium, lead, nickel, and silver originated from the heating element. Silicate particles may originate from the fiberglass wicks. Silicate nanoparticles have been found in vapors generated from the fiberglass wicks. Tin may originate from the e-cigarette solder joints. Nickel potentially found in the e-cigarette vapor may originate from the atomizer and heating coils. The nanoparticles can be produced by the heating element or by pyrolysis of chemicals directly touching the wire surface. Chromium, iron, tin, and nickel nanoparticles potentially found in the e-cigarette vapor can originate from the e-cigarette heating coils. Kanthal and nichrome are frequently used heating coils which may account for chromium and nickel in the e-cigarette vapor. Metals can originate from the "cartomizer" from the later-generation devices where an atomizer and cartridge are constructed into one unit. Metal and glass particles can be created and vaporized because of the heating of the liquid with glass fiber.
Sources: en.wikipedia.org
In 2011 in Nakhon Ratchasima, Thailand, truckloads of rotten chicken were treated with formaldehyde for sale in which "a large network", including 11 slaughterhouses run by a criminal gang, were implicated. In 2012, 1 billion rupiah (almost US$100,000) of fish imported from Pakistan to Batam, Indonesia, were found laced with formaldehyde. Formalin contamination of foods has been reported in Bangladesh, with stores and supermarkets selling fruits, fishes, and vegetables that have been treated with formalin to keep them fresh. However, in 2015, a Formalin Control Bill was passed in the Parliament of Bangladesh with a provision of life-term imprisonment as the maximum punishment as well as a maximum fine of 2,000,000 BDT but not less than 500,000 BDT for importing, producing, or hoarding formalin without a license. In the early 1900s, formaldehyde was frequently added by US milk plants to milk bottles as a method of pasteurization due to the lack of knowledge and concern regarding formaldehyde's toxicity. Formaldehyde was one of the chemicals used in 19th-century industrialized food production that was investigated by Dr. Harvey W. Wiley with his famous "Poison Squad" as part of the US Department of Agriculture. This led to the 1906 Pure Food and Drug Act, a landmark event in the early history of food regulation in the United States.
12 Feet Deep (originally titled The Deep End) is a 2017 American psychological horror-thriller film written and directed by Matt Eskandari. It stars Alexandra Park and Nora-Jane Noone as sisters who find themselves trapped inside a public swimming pool when the manager activates the pool cover and leaves for the holidays. Released by Mar Vista Entertainment on June 20, 2017, it received generally positive reviews.
On 1 April, an Israeli airstrike targeted an Iranian consulate annex building adjacent to the Iranian embassy in Damascus, Syria. It killed eight people, including a senior Quds Force commander of the IRGC, Brigadier General Mohammad Reza Zahedi. The others fatalities included five members of the Islamic Revolutionary Guards Corps and two Iranian advisors. On 8 April, Israeli officials confirmed that Hezbollah fighters shot down a Hermes 900 drone, the first of its type lost during the conflict. On 13 April, the Islamic Revolutionary Guards Corps (IRGC), a branch of the Iranian military, in collaboration with the Popular Mobilization Forces in Iraq, Hezbollah, and the Houthis in Yemen, launched attacks against Israel with drones, cruise missiles, and ballistic missiles. On 16 April, an Israeli airstrike on two cars near the town of Ain Ebel, in southern Lebanon, killed two Hezbollah members, including regional commander Ismail Baz, and one civilian. The next day, fourteen Israeli soldiers and four civilians were wounded by drones attack in northern Israel. One IDF officer died of his wounds later that week. On 23 April, an Israeli drone strike deep into Lebanon killed an engineer working for Hezbollah's air defense forces as he was traveling in a vehicle. The strike hit the Abu al-Aswad area near the coastal city of Tyre, some 35 kilometers (22 miles) from the border. The fighter's vehicle was completely burnt out. The IDF said it had killed "two significant terrorists in Hezbollah's aerial unit", the second being a senior member of the elite Redwan Force, Muhammad Attiya.
The public expected Jonas Salk or Albert Sabin to receive the prize for their development of the polio vaccines, but instead the award went to John Enders, Thomas Weller, and Frederick Robbins whose basic discovery that the polio virus could reproduce in monkey cells in laboratory preparations made the vaccines possible. Through the 1930s, there were frequent prize laureates in classical physiology, but after that, the field began fragmenting into specialities. The last classical physiology laureates were John Eccles, Alan Hodgkin, and Andrew Huxley in 1963 for their findings regarding "unitary electrical events in the central and peripheral nervous system."
Sources: en.wikipedia.org
It belongs to the incretin mimetic class and acts as a long-acting glucagon-like peptide-1 receptor agonist. The class includes several peptides with different half-lives and routes of administration.
The side chain enables reversible binding to albumin in the bloodstream, which protects the peptide from rapid renal clearance. This extends the interval between administrations compared with unmodified GLP-1.
No. It shares much of the native sequence but carries substitutions and an added side chain. These changes increase stability against enzymatic breakdown.
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and neutral endopeptidases. Semaglutide carries a non-natural amino acid at position eight that blocks that cleavage, and a fatty diacid side chain that binds albumin. The result is a much longer duration of action than the native hormone.